Cargando…
Derivation of a novel SARS–coronavirus replicon cell line and its application for anti-SARS drug screening
The severe acute respiratory syndrome (SARS) outbreak in 2002, which had a high morbidity rate and caused worldwide alarm, remains untreated today even though SARS was eventually isolated and controlled. Development and high-throughput screening of efficacious drugs is therefore critical. However, c...
Autores principales: | Ge, Feng, Luo, Yonghu, Liew, Pei Xiong, Hung, Eugene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103326/ https://www.ncbi.nlm.nih.gov/pubmed/17098272 http://dx.doi.org/10.1016/j.virol.2006.10.016 |
Ejemplares similares
-
Construction of a non-infectious SARS coronavirus replicon for application in drug screening and analysis of viral protein function
por: Wang, Jian-Min, et al.
Publicado: (2008) -
High-throughput assay using a GFP-expressing replicon for SARS-CoV drug discovery
por: Ge, Feng, et al.
Publicado: (2008) -
SARS-CoV-2 replicon for high-throughput antiviral screening
por: Zhang, Qiu-Yan, et al.
Publicado: (2021) -
Identification and Evaluation of Coronavirus Replicase Inhibitors Using a Replicon Cell Line
por: Scandella, Elke, et al.
Publicado: (2006) -
Development of A MERS-CoV Replicon Cell Line for Antiviral Screening
por: Chen, Jing, et al.
Publicado: (2021)